PORCOMPLEX is an innovative biotechnology and clinical research initiative dedicated to the development of certified transgenic pigs specifically bred for medical and transplantation applications.
Unlike conventional livestock, PORCOMPLEX animals are not intended for food production. They are raised under strict clinical, genetic, veterinary, and biosecurity protocols to support the future of regenerative medicine, xenotransplantation, tissue engineering, and advanced biomedical research.
To contribute to the global shortage of transplantable organs and biological materials by developing clinically certified transgenic porcine resources compatible with human and animal medical applications.
Human Healthcare
Organ transplantation research
Heart transplantation support
Kidney transplantation support
Liver transplantation research
Lung transplantation research
Skin graft materials
Bone regeneration materials
Biological scaffolds
Soft tissue reconstruction
Regenerative medicine
Veterinary Healthcare
Animal transplantation research
Veterinary tissue replacement
Regenerative veterinary medicine
Advanced surgical applications
PORCOMPLEX develops and studies:
Organs
Tissues
Skin
Fat tissues
Blood-derived components
Cellular materials
Regenerative biomaterials
All PORCOMPLEX animals are raised under:
Veterinary supervision
Genetic monitoring
Biosecurity protocols
Clinical traceability
Research compliance standards
Ethical oversight procedures
PORCOMPLEX is developing the first transgenic pig laboratory farm project in the Comoros Islands.
The project aims to establish:
Secure breeding facilities
Veterinary laboratories
Genetic monitoring systems
Research and development centers
International scientific partnerships
PORCOMPLEX is a biotechnology initiative developed and coordinated by MASSOURCING CORPORATION.
For information, partnerships, investment opportunities, and research collaborations:
PORCOMPLEX est une initiative innovante de biotechnologie et de recherche clinique dédiée au développement de porcs transgéniques certifiés destinés exclusivement aux applications médicales et de transplantation.
Contrairement aux élevages traditionnels, les animaux PORCOMPLEX ne sont pas destinés à l'alimentation. Ils sont élevés selon des protocoles stricts de biosécurité, de génétique, de contrôle vétérinaire et de traçabilité clinique.
Contribuer à répondre à la pénurie mondiale d'organes transplantables et de matériaux biologiques grâce au développement de ressources porcines transgéniques compatibles avec les applications médicales humaines et animales.
Santé Humaine
Recherche en transplantation d'organes
Recherche cardiaque
Recherche rénale
Recherche hépatique
Recherche pulmonaire
Greffes cutanées
Reconstruction tissulaire
Médecine régénérative
Biomatériaux médicaux
Santé Animale
Recherche vétérinaire
Remplacement tissulaire
Médecine régénérative vétérinaire
Applications chirurgicales avancées
PORCOMPLEX développe et étudie :
Organes
Tissus
Peau
Tissus graisseux
Composants biologiques
Cellules
Biomatériaux régénératifs
Tous les animaux PORCOMPLEX bénéficient :
D'un suivi vétérinaire permanent
D'un contrôle génétique
De protocoles de biosécurité
D'une traçabilité clinique complète
D'un encadrement scientifique
D'une supervision éthique
PORCOMPLEX développe le premier projet de ferme-laboratoire de porcs transgéniques aux Comores.
Le projet prévoit :
Des infrastructures sécurisées d'élevage
Des laboratoires vétérinaires
Des systèmes de contrôle génétique
Un centre de recherche et développement
Des partenariats scientifiques internationaux
PORCOMPLEX est une initiative biotechnologique développée et coordonnée par MASSOURCING CORPORATION.
Informations, partenariats et collaborations :
PORCOMPLEX es una iniciativa innovadora de biotecnología e investigación clínica dedicada al desarrollo de cerdos transgénicos certificados para aplicaciones médicas y de trasplante.
A diferencia de la ganadería convencional, los animales PORCOMPLEX no están destinados al consumo alimentario. Son criados bajo estrictos protocolos de bioseguridad, genética, supervisión veterinaria y trazabilidad clínica.
Contribuir a resolver la escasez mundial de órganos trasplantables y materiales biológicos mediante el desarrollo de recursos porcinos transgénicos compatibles con aplicaciones médicas humanas y veterinarias.
Salud Humana
Investigación en trasplante de órganos
Investigación cardíaca
Investigación renal
Investigación hepática
Investigación pulmonar
Injertos de piel
Reconstrucción de tejidos
Medicina regenerativa
Biomateriales médicos
Salud Animal
Investigación veterinaria
Sustitución de tejidos
Medicina regenerativa veterinaria
Aplicaciones quirúrgicas avanzadas
PORCOMPLEX desarrolla e investiga:
Órganos
Tejidos
Piel
Tejidos grasos
Componentes biológicos
Material celular
Biomateriales regenerativos
Todos los animales PORCOMPLEX son criados bajo:
Supervisión veterinaria
Monitoreo genético
Protocolos de bioseguridad
Trazabilidad clínica
Normas de investigación
Supervisión ética
PORCOMPLEX desarrolla el primer proyecto de granja-laboratorio de cerdos transgénicos en las Islas Comoras.
El proyecto contempla:
Instalaciones seguras de cría
Laboratorios veterinarios
Sistemas de monitoreo genético
Centros de investigación y desarrollo
Alianzas científicas internacionales
PORCOMPLEX es una iniciativa biotecnológica desarrollada y coordinada por MASSOURCING CORPORATION.
Más información, asociaciones e inversiones:
PORCOMPLEX is a research and biotechnology concept. Any clinical use involving xenotransplantation, genetically modified animals, human transplantation, animal transplantation, or biological products must comply with all applicable national and international laws, ethical standards, regulatory approvals, veterinary regulations, and public health requirements.
PORCOMPLEX est un concept de recherche et de biotechnologie. Toute application clinique doit respecter les réglementations nationales et internationales en vigueur.
PORCOMPLEX es un concepto de investigación y biotecnología. Toda aplicación clínica debe cumplir con las normativas nacionales e internacionales aplicables.
$1 BILLION FOR 1%
Exclusive off-market capitalization opportunity.
Only 10% of the project available for release.
Starting from $100,000,000 USD
$100M commitment for 10 years of corporate communication and strategic visibility.
+---------------------------+
| SPONSOR |
| YOU HERE |
| PREMIER |
| PORCOMPLEX™ |
+---------------------------+
Support the project with official merchandise.
Starting from $30 USD
Examples:
Mugs
Tote Bags
Sticker Sheets
Promotional Items
Free Worldwide Shipping
Starting from $50,000,000 USD
Starting from $500 USD
Donations can be made through our partner:
DONORBOX.ORG
For all orders, donations, sponsorships and online payments:
THERA.PORCOMPLEX.COM
Funds raised are intended to support the development of the PORCOMPLEX™ ecosystem, including:
Acquisition of biotechnology companies, laboratories, intellectual property and patents related to the target field.
Development of environmentally responsible GMO pig farming facilities.
Energy-autonomous and eco-friendly infrastructures.
HSE, quality and international certification programs.
Research and development of robotic medical systems.
Design of advanced clinical and laboratory facilities.
Development of AI-assisted medical technologies.
Research into collagen, biomolecules and other biotechnology-derived products.
Clinical research programs and validation studies where legally authorized.
Patent filing and intellectual property protection.
Telemedicine platforms and connected healthcare technologies.
Creation of an integrated biotechnology, healthcare and robotics ecosystem.
Vertical integration from breeding and production to medical and technological applications.
$100,000,000 USD
$10,000,000,000 USD
To build a global ecosystem combining:
GMO Pig Biotechnology
Medical Applications
Health Technologies
Artificial Intelligence
Robotics
Telemedicine
Advanced Manufacturing
KALID OMANAA
Business Development
MASSOURCING CORPORATION
PORCOMPLEX™
Biotech • Medical Innovation • Robotics • AI • Research & Development